Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mengping Long

Showing results (1-10 of 40) with videos related to

Pageof 4
Sort By:
F1000Research|July 2, 2016
Tripartite genome of all speciesMengPing Long, TaoBo Hu
Technology in Cancer Research & Treatment|June 23, 2021
A Machine Learning Approach to Differentiate Two Specific Breast Cancer Subtypes Using Androgen Receptor Pathway GenesTaobo Hu, Guiyang Zhao, Yiqiang Liu, et al.
Genes & Diseases|July 5, 2022
Mechanism and effect of stress granule formation in cancer and its potential roles in breast cancer therapyTaobo Hu, Wei Hou, Enhua Xiao, et al.
Current Oncology (Toronto, Ont.)|February 22, 2021
A Histone Acetylation Modulator Gene Signature for Classification and Prognosis of Breast CancerMengping Long, Wei Hou, Yiqiang Liu, et al.
Life (Basel, Switzerland)|June 27, 2024
Bridging Discoveries and Treatments: The New Landscape of Breast Cancer ResearchTaobo Hu, Lei Wang, Riccardo Autelli, et al.
Gland Surgery|March 4, 2022
Modeling effective tumor burden of primary lesion and metastatic lymph node in breast cancer patients from the SEER databaseTaobo Hu, Jinbo Wu, Mengping Long, et al.
BMC Women'S Health|April 15, 2022
Intraparenchymal breast leiomyoma and atypical leiomyomaMengping Long, Xuejiao Lina Hu, Guiyang Zhao, et al.
Life (Basel, Switzerland)|December 23, 2022
Adverse Events of PD-1 or PD-L1 Inhibitors in Triple-Negative Breast Cancer: A Systematic Review and Meta-AnalysisYixi Zhang, Jingyuan Wang, Taobo Hu, et al.
Journal of Experimental & Clinical Cancer Research : CR|July 27, 2025
Comparing Xenium 5K and Visium HD data from identical tissue slide at a pathological perspectiveMengping Long, Taobo Hu, Weixin Wang, et al.
BMC Medical Research Methodology|May 23, 2021
Classification of PR-positive and PR-negative subtypes in ER-positive and HER2-negative breast cancers based on pathway scoresTaobo Hu, Yan Chen, Yiqiang Liu, et al.
Pageof 4

Showing results (1-10 of 40) with videos related to

Sort By:
Pageof 4
F1000Research|July 2, 2016
Tripartite genome of all speciesMengPing Long, TaoBo Hu
Technology in Cancer Research & Treatment|June 23, 2021
A Machine Learning Approach to Differentiate Two Specific Breast Cancer Subtypes Using Androgen Receptor Pathway GenesTaobo Hu, Guiyang Zhao, Yiqiang Liu, et al.
Genes & Diseases|July 5, 2022
Mechanism and effect of stress granule formation in cancer and its potential roles in breast cancer therapyTaobo Hu, Wei Hou, Enhua Xiao, et al.
Current Oncology (Toronto, Ont.)|February 22, 2021
A Histone Acetylation Modulator Gene Signature for Classification and Prognosis of Breast CancerMengping Long, Wei Hou, Yiqiang Liu, et al.
Life (Basel, Switzerland)|June 27, 2024
Bridging Discoveries and Treatments: The New Landscape of Breast Cancer ResearchTaobo Hu, Lei Wang, Riccardo Autelli, et al.
Gland Surgery|March 4, 2022
Modeling effective tumor burden of primary lesion and metastatic lymph node in breast cancer patients from the SEER databaseTaobo Hu, Jinbo Wu, Mengping Long, et al.
BMC Women'S Health|April 15, 2022
Intraparenchymal breast leiomyoma and atypical leiomyomaMengping Long, Xuejiao Lina Hu, Guiyang Zhao, et al.
Life (Basel, Switzerland)|December 23, 2022
Adverse Events of PD-1 or PD-L1 Inhibitors in Triple-Negative Breast Cancer: A Systematic Review and Meta-AnalysisYixi Zhang, Jingyuan Wang, Taobo Hu, et al.
Journal of Experimental & Clinical Cancer Research : CR|July 27, 2025
Comparing Xenium 5K and Visium HD data from identical tissue slide at a pathological perspectiveMengping Long, Taobo Hu, Weixin Wang, et al.
BMC Medical Research Methodology|May 23, 2021
Classification of PR-positive and PR-negative subtypes in ER-positive and HER2-negative breast cancers based on pathway scoresTaobo Hu, Yan Chen, Yiqiang Liu, et al.
Pageof 4